[Antimicrobial susceptibility patterns of clinical isolates of Pseudomonas cepacia (author's transl)]. 1979

J Igari, and N Kosakai, and T Oguri

The yearly changes of relative frequency of glucose-nonfermentative Gram-negative bacilli except for P. aeruginosa isolated from various clinical specimens over the past 5 years were studied. Acinetobacter anitratum was the most commonly encountered strain and P. maltophilia and P. putida were also frequently encountered during 1974 through 1977. In 1978, P. cepacia became a significantly predominant strain, which was 44.6% of all nonfermentative Gram-negative bacilli excluding P. aeruginosa isolated in Juntendo Hospital. Antimicrobial susceptibility patterns of 59 similar to 61 clinical isolates of P. cepacia in 1978 were studied by agar dilution method, standardized by the Japan Society of Chemotherapy. Miloxacin and minocycline inhibited more than 95% of the strain by the concentration of 6.25 micrograms/ml. Nalidixic acid and sulfamethoxazole were sensitive to approximately 52% and 75% of the strains respectively. The minimal inhibitory concentration of gentamicin, tobramycin, amikacin, kanamycin, apalcillin, piperacillin and pipemidic acid for most strains was more than 1.25 micrograms/ml. More than 90% of the strains were highly resistant to ampicillin, carbenicillin, sulbenicillin, ticarcillin, cefazolin, cefotiam, tetracycline, clindamycin and colistin.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D010403 Penicillin Resistance Nonsusceptibility of an organism to the action of penicillins. Penicillin Resistances,Resistance, Penicillin,Resistances, Penicillin
D010406 Penicillins A group of antibiotics that contain 6-aminopenicillanic acid with a side chain attached to the 6-amino group. The penicillin nucleus is the chief structural requirement for biological activity. The side-chain structure determines many of the antibacterial and pharmacological characteristics. (Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1065) Antibiotics, Penicillin,Penicillin,Penicillin Antibiotics
D011549 Pseudomonas A genus of gram-negative, aerobic, rod-shaped bacteria widely distributed in nature. Some species are pathogenic for humans, animals, and plants. Chryseomonas,Pseudomona,Flavimonas
D000617 Aminoglycosides Glycosylated compounds in which there is an amino substituent on the glycoside. Some of them are clinically important ANTIBIOTICS. Aminoglycoside
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial

Related Publications

J Igari, and N Kosakai, and T Oguri
March 1977, Rinsho byori. The Japanese journal of clinical pathology,
J Igari, and N Kosakai, and T Oguri
August 1978, The Japanese journal of antibiotics,
J Igari, and N Kosakai, and T Oguri
March 1995, The Canadian veterinary journal = La revue veterinaire canadienne,
J Igari, and N Kosakai, and T Oguri
June 2004, Saudi medical journal,
J Igari, and N Kosakai, and T Oguri
October 1973, Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. Erste Abteilung Originale. Reihe A: Medizinische Mikrobiologie und Parasitologie,
J Igari, and N Kosakai, and T Oguri
May 1987, Gaoxiong yi xue ke xue za zhi = The Kaohsiung journal of medical sciences,
J Igari, and N Kosakai, and T Oguri
December 2003, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia,
J Igari, and N Kosakai, and T Oguri
March 2006, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia,
J Igari, and N Kosakai, and T Oguri
January 1989, Chemotherapy,
J Igari, and N Kosakai, and T Oguri
December 1986, The Journal of the Oklahoma State Medical Association,
Copied contents to your clipboard!